These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


521 related items for PubMed ID: 15743841

  • 1. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
    Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H.
    Mol Cell Biol; 2005 Mar; 25(6):2498-510. PubMed ID: 15743841
    [Abstract] [Full Text] [Related]

  • 2. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H, Katagiri H, Funaki M, Anai M, Inukai K, Fukushima Y, Sakoda H, Ogihara T, Onishi Y, Fujishiro M, Kikuchi M, Oka Y, Asano T.
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [Abstract] [Full Text] [Related]

  • 3. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A.
    J Biol Chem; 2005 Jun 10; 280(23):22523-9. PubMed ID: 15824124
    [Abstract] [Full Text] [Related]

  • 4. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice.
    Shao J, Yamashita H, Qiao L, Friedman JE.
    J Endocrinol; 2000 Oct 10; 167(1):107-15. PubMed ID: 11018758
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats.
    Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM.
    J Clin Invest; 2004 Jul 10; 114(2):224-31. PubMed ID: 15254589
    [Abstract] [Full Text] [Related]

  • 6. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected].
    Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA, Wu H.
    Proc Natl Acad Sci U S A; 2004 Feb 17; 101(7):2082-7. PubMed ID: 14769918
    [Abstract] [Full Text] [Related]

  • 7. Muscle-specific Pten deletion protects against insulin resistance and diabetes.
    Wijesekara N, Konrad D, Eweida M, Jefferies C, Liadis N, Giacca A, Crackower M, Suzuki A, Mak TW, Kahn CR, Klip A, Woo M.
    Mol Cell Biol; 2005 Feb 17; 25(3):1135-45. PubMed ID: 15657439
    [Abstract] [Full Text] [Related]

  • 8. PTEN does not modulate GLUT4 translocation in rat adipose cells under physiological conditions.
    Mosser VA, Li Y, Quon MJ.
    Biochem Biophys Res Commun; 2001 Nov 09; 288(4):1011-7. PubMed ID: 11689011
    [Abstract] [Full Text] [Related]

  • 9. Pten signaling in gliomas.
    Knobbe CB, Merlo A, Reifenberger G.
    Neuro Oncol; 2002 Jul 09; 4(3):196-211. PubMed ID: 12084351
    [Abstract] [Full Text] [Related]

  • 10. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice.
    Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean NM, Bhanot S, Monia BP.
    Diabetes; 2002 Apr 09; 51(4):1028-34. PubMed ID: 11916922
    [Abstract] [Full Text] [Related]

  • 11. Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules.
    Song H, Shojima N, Sakoda H, Ogihara T, Fujishiro M, Katagiri H, Anai M, Onishi Y, Ono H, Inukai K, Fukushima Y, Kikuchi M, Shimano H, Yamada N, Oka Y, Asano T.
    Biochem Biophys Res Commun; 2002 Nov 29; 299(2):291-8. PubMed ID: 12437985
    [Abstract] [Full Text] [Related]

  • 12. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A.
    Endocrinology; 2005 Mar 29; 146(3):1328-37. PubMed ID: 15576463
    [Abstract] [Full Text] [Related]

  • 13. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T, Wada T, Tsuneki H.
    Pharmacol Ther; 2006 Dec 29; 112(3):799-809. PubMed ID: 16842857
    [Abstract] [Full Text] [Related]

  • 14. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W.
    Oncogene; 2002 Aug 08; 21(34):5289-300. PubMed ID: 12149650
    [Abstract] [Full Text] [Related]

  • 15. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes.
    Nakashima N, Sharma PM, Imamura T, Bookstein R, Olefsky JM.
    J Biol Chem; 2000 Apr 28; 275(17):12889-95. PubMed ID: 10777587
    [Abstract] [Full Text] [Related]

  • 16. Pancreas-specific Pten deficiency causes partial resistance to diabetes and elevated hepatic AKT signaling.
    Tong Z, Fan Y, Zhang W, Xu J, Cheng J, Ding M, Deng H.
    Cell Res; 2009 Jun 28; 19(6):710-9. PubMed ID: 19365404
    [Abstract] [Full Text] [Related]

  • 17. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.
    Whang YE, Yuan XJ, Liu Y, Majumder S, Lewis TD.
    Vitam Horm; 2004 Jun 28; 67():409-26. PubMed ID: 15110188
    [Abstract] [Full Text] [Related]

  • 18. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes.
    Ikubo M, Wada T, Fukui K, Ishiki M, Ishihara H, Asano T, Tsuneki H, Sasaoka T.
    Am J Physiol Endocrinol Metab; 2009 Jan 28; 296(1):E157-64. PubMed ID: 19001549
    [Abstract] [Full Text] [Related]

  • 19. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL, Sheng X, Hortobagyi ZK, Mao Z, Gallick GE, Yung WK.
    Mol Cell Biol; 2005 Jul 28; 25(14):6211-24. PubMed ID: 15988030
    [Abstract] [Full Text] [Related]

  • 20. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE, Donner DB.
    Proc Natl Acad Sci U S A; 2001 Apr 10; 98(8):4640-5. PubMed ID: 11287630
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.